- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- December 2023
- 171 Pages
Global
From €3989EUR$4,000USD£3,332GBP
- Report
- October 2023
- 259 Pages
Global
From €3989EUR$4,000USD£3,332GBP
- Report
- September 2023
- 50 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- January 2024
- 172 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- September 2022
- 120 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- January 2024
- 200 Pages
Global
From €4139EUR$4,150USD£3,457GBP
- Report
- June 2023
- 65 Pages
Global
From €3984EUR$3,995USD£3,328GBP
- Report
- April 2023
- 78 Pages
Global
From €3486EUR$3,495USD£2,911GBP
- Report
- March 2023
- 187 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- February 2023
- 81 Pages
Global
From €3486EUR$3,495USD£2,911GBP
- Report
- May 2022
- 208 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- May 2022
- 471 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- April 2022
- 204 Pages
Global
From €4987EUR$5,000USD£4,165GBP
- Report
- March 2022
- 1284 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Clinical Trials
- November 2021
- 929 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Clinical Trials
- November 2021
- 259 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Clinical Trials
- August 2021
- 276 Pages
Global
From €2493EUR$2,500USD£2,083GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more